vials of compounded semaglutide As Ozempic demand climbs, patients turn to versions Hims is in the crosshairs.

Discover what current FDA data and clinical trials reveal about GLP-1 medications like Ozempic, Wegovy, and Mounjaro and cancer safety concerns.

But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.

{eople seeking better weight management strategies, for whom GLP-1 drugs like Wegovy alone do not work, may benefit more from a combination treatment, a recent review of the evidence suggests.

Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.

By early 2025, nearly 25% of diabetes patients had started a GLP1 therapy, up from just 3% four years ago

Beyond weight loss: The hidden benefits of GLP-1